364 related articles for article (PubMed ID: 22110523)
1. T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.
Amedei A; Niccolai E; D'Elios MM
Clin Dev Immunol; 2011; 2011():320571. PubMed ID: 22110523
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
Elkord E; Hawkins RE; Stern PL
Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer: recent developments in medical oncology.
Chong G; Cunningham D
Eur J Surg Oncol; 2005 Jun; 31(5):453-60. PubMed ID: 15922879
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
[TBL] [Abstract][Full Text] [Related]
6. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
Wang DK; Zuo Q; He QY; Li B
Front Immunol; 2021; 12():705999. PubMed ID: 34447376
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for gastrointestinal malignancies.
Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in Gastrointestinal Malignancies.
Mizrahi J; Pant S
Adv Exp Med Biol; 2020; 1244():93-106. PubMed ID: 32301012
[TBL] [Abstract][Full Text] [Related]
9. Developments in immunotherapy for gastrointestinal cancer.
Diaz JL; Wanta SM; Fishbein TM; Kroemer A
Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
[TBL] [Abstract][Full Text] [Related]
10. New Perspective on the Treatment of Intractable Gastrointestinal Cancers: Role of Combination Therapies.
Duda DG
Keio J Med; 2017; 66(4):72. PubMed ID: 29276214
[TBL] [Abstract][Full Text] [Related]
11. [Oncology, what's new in 2018].
Latifyan S; Kakourou A; Ozdemir B; Zaman K; Vernadou A; Berthold D; Abdelhamid K; Bouchaab H; Peters S; Montemurro M; Aedo V; Michielin O; Zimmermann S; Stravodimou A
Rev Med Suisse; 2019 Jan; 15(N° 632-633):78-81. PubMed ID: 30629376
[TBL] [Abstract][Full Text] [Related]
12. A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.
Mathur D; Root AR; Bugaj-Gaweda B; Bisulco S; Tan X; Fang W; Kearney JC; Lucas J; Guffroy M; Golas J; Rohde CM; Stevens C; Kamperschroer C; Kelleher K; Lawrence-Henderson RF; Upeslacis E; Yao J; Narula J; LaVallie ER; Fernandez DR; Buetow BS; Rosfjord E; Bloom L; King LE; Tchistiakova L; Nguyen A; Sapra P
Clin Cancer Res; 2020 May; 26(9):2188-2202. PubMed ID: 31996389
[TBL] [Abstract][Full Text] [Related]
13. T cell immunotherapy.
McKee MD; Fichera A; Nishimura MI
Front Biosci; 2007 Jan; 12():919-32. PubMed ID: 17127349
[TBL] [Abstract][Full Text] [Related]
14. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
Bhargava A; Mishra D; Banerjee S; Mishra PK
J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
[TBL] [Abstract][Full Text] [Related]
15. [ASCO-update 2015 - highlights of the 51. meeting of the american society of clinical oncology/ASCO 2015].
Lorenzen S; Arnold D; Fottner C; Leichsenring J; Moehler M; Seufferlein T; Vogel A; Weber MM; Reinacher-Schick A
Z Gastroenterol; 2016 Feb; 54(2):167-72. PubMed ID: 26854837
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
17. Surgical oncology in the age of multimodality therapy for cancer of the upper and lower gastrointestinal tract.
Neumann PA; Berlet MW; Friess H
Expert Rev Anticancer Ther; 2021 May; 21(5):511-522. PubMed ID: 33355020
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
Blair AB; Murphy A
Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
Zhou C; Zhang J
Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer and the epoch of immunotherapy approaches.
Niccolai E; Taddei A; Prisco D; Amedei A
World J Gastroenterol; 2015 May; 21(19):5778-93. PubMed ID: 26019442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
